Your browser doesn't support javascript.
loading
Rituximab-treated rheumatic patients: B cells predict seroconversion after COVID-19 boost or revaccination in initial vaccine non-responders.
Ammitzbøll, Christian; Kragh Thomsen, Marianne; Bøgh Andersen, Jakob; Jensen, Jens Magnus Berth; From Hermansen, Marie-Louise; Dahl Johannsen, Anders; Larsen, Mads Lamm; Mistegaard, Clara Elbæk; Mikkelsen, Susan; Szabados, Fruzsina; Vils, Signe Risbøl; Erikstrup, Christian; Hauge, Ellen-Margrethe; Troldborg, Anne.
Afiliação
  • Ammitzbøll C; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
  • Kragh Thomsen M; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Bøgh Andersen J; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Jensen JMB; Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark.
  • From Hermansen ML; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
  • Dahl Johannsen A; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
  • Larsen ML; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Mistegaard CE; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
  • Mikkelsen S; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
  • Szabados F; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
  • Vils SR; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
  • Erikstrup C; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Hauge EM; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
  • Troldborg A; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Rheumatology (Oxford) ; 62(7): 2544-2549, 2023 07 05.
Article em En | MEDLINE | ID: mdl-36445008
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Dinamarca